VOLITIONRX LTD — Director's Dealing 2020

Jul 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-07-21

Reporting Person: Rootsaert Rodney Gerard (Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-21	Common Stock	M	30000	$2.5	Acquired	39828	Direct
2020-07-21	Common Stock	F	23614	$3.95	Disposed	16214	Direct
2020-07-21	Common Stock	M	30000	$3	Acquired	46214	Direct
2020-07-21	Common Stock	F	25816	$3.95	Disposed	20398	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-21	Stock Option (Right to Buy)	$2.5	M	30000	Disposed	2020-08-18	Common Stock (30000)	Direct
2020-07-21	Stock Option (Right to Buy)	$3	M	30000	Disposed	2020-08-18	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1007718	Indirect

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.

F2: The shares of Common Stock are held directly by Concord International, Inc. Mr. Rootsaert is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.